Add like
Add dislike
Add to saved papers

Small nucleolar RNA 47 promotes tumorigenesis by regulating EMT markers in hepatocellular carcinoma.

Minerva Medica 2017 October
BACKGROUND: Hepatocellular carcinoma (HCC) is third leading cause of cancer-related death globally. Evidence suggest that small nucleolar RNAs (snoRNAs) have emerged as key regulators of tumor development and progression in HCC. However, the biological significance of snoRNAs in HCC remains unclear.

METHODS: We investigated the role of snoRA47 in a total of 60 paired HCC samples and six different human HCC cell lines by using qRT-PCR. Besides, snoRA47 was silenced through the siRNA transfection to determine whether snoRA47-siRNA is able to affect cell proliferation, invasion and metastasis by regulating the expressions of "epithelial-mesenchymal transition'' (EMT) markers.

RESULTS: The expression of snoRA47 in HCC tissues was significantly higher than that in adjacent normal tissues (non-diseased tissues) and it was remarkably associated with intrahepatic metastasis, lymphatic invasion, and TNM stage. The Kaplan-Meier survival curves suggested that HCC patients with high snoRA47 expression experienced significantly shorter overall survival and statistically higher recurrence rate than those with low expression of snoRA47. In addition, it was proved that the knockdown of snoRA47 inhibited cell proliferation by inducing cell apoptosis and suppressed cell invasion and migration by regulating the expressions of EMT markers.

CONCLUSIONS: SnoRA47 may serve as a valuable biomarker and a potential therapeutic target for HCC.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app